Real-time Analytics
Bristol Myers Squibb needed to shorten expensive, operationally complex Phase III clinical trials and give research teams faster, clearer visibility into trial performance so they could react to issues earlier and bring therapies to patients more quickly.
Reported impact
Bristol Myers Squibb accelerated priority clinical trials, expanded use of a common trial-operations platform, improved visibility into key execution risks, and gave teams a faster way to learn from past studies and act before operational problems delay development.
Bristol Myers Squibb and Accenture built Workbench as a clinical-trial accelerator that combines generative AI, automation, and real-time operational data for drug-development teams. The broader partnership implemented more than 30 generative AI solutions across R&D, product development and supply, and commercialization, but Workbench became a focal system for trial operations. It gathers structured and unstructured trial data, organizes it into decision-ready views, and presents actionable insights to project teams. A recommendation feature tailors guidance by user role, study type, and trial context, while analysis of current and historical data helps anticipate emerging issues and propose interventions before delays grow. By integrating insights across transactional systems into one trusted operating layer, Workbench shifts trial execution from reactive coordination to proactive management and standardizes best practices across priority clinical programs.
Structured and unstructured clinical-trial data is gathered into Workbench, where automation and generative AI organize it into decision-ready views. The recommendation feature analyzes current and historical signals by user role, study type, and trial context, then returns actionable guidance and issue-prevention insights to project teams through the Workbench interface.
"A key outcome of the BMS-Accenture partnership is 'Workbench', a clinical trial accelerator that fuses AI-driven insights with real-time operational data."
"Now adopted by over 30 of BMS’ top priority clinical trial teams, with unique users of the platform surging from under 100 to nearly 900 in just 3 months"
"Workbench includes a recommendation feature delivering insights based on user role, study type, and trial context"
"the company successfully implemented more than 30 generative AI solutions across its Research & Development, Global Product Development & Supply, and Commercialization divisions."
"the tool also anticipates issues and suggests interventions."
Review how this reference was scored and trace each normalized claim back to its documented source.
Scoring methodology
Customer Reference Value measures usefulness as a customer reference. Evidence Confidence measures the quality and traceability of available evidence, not independent verification.
Traceability
Field coverage shows which facts each source supports. Dates are shown only when documented by the source.
Related
Accenture Sample Aug 14, 2026 Novartis Novartis needed to unify fragmented data across R&D, manufacturing, commercial, and corporate functions so teams could analyze growing biomedical and operational data sets faster and apply AI to drug development and… 10 days to three days Amazon Web Services (AWS) · Microsoft Azure · analytics tools supported by AI and ML 
Databricks Sample Oct 8, 2026 ModMed ModMed needed to protect sensitive patient data and maintain compliance while reducing administrative overhead, improving access to operational data, and creating AI-enabled products and agentic workflows for ambulatory… Databricks Data + AI Platform · Genie Agents · Genie Code Accenture Sample Aug 13, 2026 Duke Energy Duke Energy needed to go beyond current US EPA regulations and replace slow physical inspection-based leak surveys with a rigorous end-to-end way to detect, monitor, and remediate methane emissions across its natural… net-zero methane goals for 2030 Azure-based cloud platform · analytics · artificial intelligence 